Stryker Corporation

Stryker operates as a medical technology company with two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics segment provides implants for joint replacements and spinal surgeries. The MedSurg and Neurotechnology segment offers surgical equipment, navigation systems, and medical devices for various specialties. The company sells products to doctors, hospitals, and healthcare facilities through subsidiaries, branches, dealers, and distributors in 75 countries.

Overview

Sector

Medical Devices

Target Price

180.4 USD

Current Price

381.6 USD

Potential

-53%

Strengths

The company has high returns. ROIC (12.39%) is higher than the sector mean (2.97%).
Strong EBITDA Margin of 29.62%.

Weaknesses

With a depreciation Potential of -52.35%, based on our fundamental analysis, it suggests the stock may be overvalued.
The company has high debt. Net Debt to EBITDA Ratio (1.49) is higher than the sector mean.

Key Financial Data

Indicator	Value
PER	48.6
EV/EBITDA	23.2
Price/Free Cash Flow'	41.7
ROIC	12.4%
Net Debt/EBITDA	1.5